ALSN Vol. 15, No. 5

Topics include new thinking about how ALS develops and progresses, and progress in testing nearly 30 compounds targeting ALS-related pathways

Posted on Wednesday, September 1, 2010 - 09:39, By: Margaret Wahl
The ALS TDI, an MDA-supported, nonprofit biotechnology organization in Cambridge, Mass., hosted a public webinar (online seminar) on July 27, 2010. Below is a summary of the main points of the report, which is archived on the ALS TDI website. Many compounds in development
Posted on Wednesday, September 1, 2010 - 09:34, By: Amy Madsen
MDA has awarded 10 grants totaling nearly $3.5 million to fund research projects focused on uncovering the causes of and developing therapies for ALS. The new grants went to investigators at labs in the United States, Canada and Israel.
Posted on Wednesday, September 1, 2010 - 09:27, By: ALSN Staff
With the holidays just around the corner and air travel likely for many families, now is the opportune time for people with disabilities to carefully plan their sojourns. Learn from others “Traveling with a disability is not easy, but with some extra preplanning and research, it is completely...

Of mice and men: Is a research mouse with familial ALS a good model for nonfamilial ALS? Yes, say researchers, and here's why

Posted on Wednesday, September 1, 2010 - 09:18, By: Amy Madsen
Animal models — research animals with a form of the disease being studied — are one of the most important tools in ALS research today, says Fernando Vieira, director of in vivo validation at the ALS Therapy Development Institute (ALS TDI) of Cambridge, Mass.